Literature DB >> 17641149

Evidence for multiple retroposition events and gene evolution in the ADP/ATP translocase gene family in Ranid frogs.

Chikako Matsuba1, Jukka Uolevi Palo, Sergius L Kuzmin, Juha Merilä.   

Abstract

Analysis of partial ADP/ATP Translocase gene (Aat) sequences from 11 species of Ranid frogs (Amphibia: Ranidae) identified multiple Aat gene copies. All frog species examined had at least one of the 2 Aat gene copies differing mainly by presence or absence of an approximately 85-bp intron sequence. The sequence data suggest that the gene variant with intron is the ancestral Aat form, whereas the other variants are retroposed copies. Surprisingly, a phylogenetic analysis suggests that multiple reptroposition events have taken place in the Ranid frogs. An analysis including sequences from Drosophila, zebra fish, Xenopus, mouse, and human indicated that all the frog Aat sequences form a monophyletic group with mammalian X-chromosomal Ant2 as a sister unit. Furthermore, the selection test suggested that different variants of the Aat gene appear to have evolved under different modes of evolution (viz., neutral, purifying, and positive selection), and the evolutionary history of different AAT variants appears to differ even among different species.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17641149     DOI: 10.1093/jhered/esm038

Source DB:  PubMed          Journal:  J Hered        ISSN: 0022-1503            Impact factor:   2.645


  2 in total

Review 1.  Brain sex matters: estrogen in cognition and Alzheimer's disease.

Authors:  Rena Li; Jie Cui; Yong Shen
Journal:  Mol Cell Endocrinol       Date:  2014-01-11       Impact factor: 4.102

2.  Genomic signatures of thermal adaptation are associated with clinal shifts of life history in a broadly distributed frog.

Authors:  Hugo Cayuela; Yann Dorant; Brenna R Forester; Dan L Jeffries; Rebecca M Mccaffery; Lisa A Eby; Blake R Hossack; Jérôme M W Gippet; David S Pilliod; W Chris Funk
Journal:  J Anim Ecol       Date:  2021-06-18       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.